Section
Recent research indicates that patients with type 2 diabetes who use SGLT2 inhibitors after a urinary tract infection have a lower mortality risk compared to those using DPP-4 inhibitors.
A multi‑institutional Advanced Science study links PTFE microplastic bioaccumulation to impaired spermatogenesis via SKAP2 suppression and shows that SKAP2‑rich milk‑derived extracellular vesicles restore sperm structure and function in hum
In 1,142 patients aged 8–21, a nonrandomized multicenter trial found no clinically meaningful difference in 6-week sonographic stone clearance between ureteroscopy and shockwave lithotripsy; SWL was associated with less pain and fewer misse
KEYNOTE-991 shows pembrolizumab does not improve progression-free or overall survival for mHSPC, and increases serious adverse events when added to enzalutamide and ADT.
Discover the optimal abstinence period for male fertility and learn how lifestyle choices impact sperm quality.
Ejaculation control is a common concern for men, impacting confidence and relationships. This article explores causes, solutions, and practical strategies for improvement.
Discover how aerobic exercise, strength training, and pelvic floor exercises can enhance men’s sexual function, supported by clinical evidence and expert advice.
Explore the scientific principles and practical strategies of using squats to boost male sexual health, supported by research and expert insights.
Treatment for advanced prostate cancer has advanced significantly in the past decade, but metastatic castration-resistant...
Testosterone therapy offers modest benefits for sexual function, anemia, and bone health in older men with hypogonadism, but increases risks of venous thromboembolism, fractures, and arrhythmias. Careful patient selection and individualized
Pelvic inflammatory disease (PID) commonly presents with lower abdominal pain, abnormal vaginal discharge, and systemic symptoms like fever. Early recognition and treatment are vital to prevent complications.
Recent high-quality evidence indicates that Serenoa repens provides little to no benefit for lower urinary tract symptoms due to benign prostatic enlargement compared to placebo.
Exploring the relationship between calcium intake and kidney stones, this article provides evidence-based guidance for patients and health professionals.
The EV-302 trial shows enfortumab vedotin plus pembrolizumab improves survival and quality of life over platinum-based chemotherapy in untreated advanced urothelial cancer patients.
The PACE-C phase 3 trial shows that stereotactic body radiotherapy (SBRT) and moderately hypofractionated radiotherapy (MHRT) have comparable early toxicity profiles in intermediate- and high-risk prostate cancer patients.
The CONTACT-02 phase 3 trial shows cabozantinib plus atezolizumab improves progression-free survival but not overall survival in advanced mCRPC post-ARPI, offering a novel non-androgen receptor-based option.
A Danish multicentre trial found individualised, shorter antibiotic regimens for febrile pediatric UTIs reduce overall antibiotic exposure and adverse events, but with a modestly higher recurrence risk compared to standard 10-day treatment.
The DoxyPEP trial demonstrates that doxycycline post-exposure prophylaxis markedly lowers bacterial STI incidence in men who have sex with men and transgender women, with good tolerability and minimal resistance over 12 months.
Recent large RCTs show metformin does not improve survival or reduce metabolic syndrome risk in prostate cancer patients on ADT, though it modestly improves metabolic parameters.
A phase 1/2 trial demonstrates the safety of [161Tb]Tb-PSMA-I&T, a novel dual beta-Auger radioligand, in heavily pretreated metastatic castration-resistant prostate cancer patients, supporting further clinical investigation.
